Takeshi Harada

4.6k total citations
120 papers, 3.1k citations indexed

About

Takeshi Harada is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Takeshi Harada has authored 120 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 49 papers in Hematology and 30 papers in Oncology. Recurrent topics in Takeshi Harada's work include Multiple Myeloma Research and Treatments (45 papers), Histone Deacetylase Inhibitors Research (13 papers) and Protein Degradation and Inhibitors (13 papers). Takeshi Harada is often cited by papers focused on Multiple Myeloma Research and Treatments (45 papers), Histone Deacetylase Inhibitors Research (13 papers) and Protein Degradation and Inhibitors (13 papers). Takeshi Harada collaborates with scholars based in Japan, United States and Italy. Takeshi Harada's co-authors include Eisuke Nishida, Satoshi Ogawa, Takaya Morooka, Teru Hideshima, Masahiro Abe, Kenneth C. Anderson, Toshio Matsumoto, Shuji Ozaki, Shingen Nakamura and Hirokazu Miki and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Takeshi Harada

102 papers receiving 3.0k citations

Peers

Takeshi Harada
Shoko Yoshida Japan
Xiaonan Wang China
Liting Chen China
Gerhard Weber Germany
Kenji Saito Japan
KM Taylor United Kingdom
Agnete Larsen Denmark
Yan Chen China
Yanli Zhang China
Xujun Wang China
Shoko Yoshida Japan
Takeshi Harada
Citations per year, relative to Takeshi Harada Takeshi Harada (= 1×) peers Shoko Yoshida

Countries citing papers authored by Takeshi Harada

Since Specialization
Citations

This map shows the geographic impact of Takeshi Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Harada more than expected).

Fields of papers citing papers by Takeshi Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Harada. The network helps show where Takeshi Harada may publish in the future.

Co-authorship network of co-authors of Takeshi Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Harada. A scholar is included among the top collaborators of Takeshi Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Harada. Takeshi Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Shingen, et al.. (2025). False-Positive Galactomannan Test Results in Multiple Myeloma. Diseases. 13(4). 118–118.
2.
Yamanishi, Tadashi, et al.. (2024). Swallowing-like activity elicited in neonatal rat medullary slice preparation. Brain Research. 1837. 148955–148955. 1 indexed citations
3.
Sogabe, Kimiko, et al.. (2024). Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma. Internal Medicine. 64(8). 1223–1228. 1 indexed citations
4.
Harada, Takeshi, et al.. (2024). Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis. The Journal of Medical Investigation. 71(3.4). 335–339.
5.
Takao, Shoichiro, Michiko Yamashita, Kimiko Sogabe, et al.. (2024). Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study. BMJ Supportive & Palliative Care. 15(5). 672–676.
6.
Ohguchi, Hiroto, Sho Kubota, Shingo Usuki, et al.. (2024). Multiple myeloma–associated DIS3 gene is essential for hematopoiesis, but loss of DIS3 is insufficient for myelomagenesis. PubMed. 1(1). 100005–100005.
7.
Inoue, Yusuke, Jumpei Teramachi, Asuka Oda, et al.. (2024). Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction. Cancer Science. 116(2). 559–563. 1 indexed citations
8.
Inoue, Yusuke, Asuka Oda, Kimiko Sogabe, et al.. (2024). Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid. International Journal of Hematology. 119(6). 626–630. 1 indexed citations
9.
10.
11.
Kagawa, Kumiko, Takashi Saito, Kimiko Sogabe, et al.. (2021). Allogeneic haematopoietic stem cell transplantation—clinical outcomes: impact of leg muscle strength. BMJ Supportive & Palliative Care. 16(1). 180–187. 6 indexed citations
12.
Nunoura, Takuro, Yoshito Chikaraishi, Takaaki Sato, et al.. (2018). A primordial and reversible TCA cycle in a facultatively chemolithoautotrophic thermophile. Science. 359(6375). 559–563. 148 indexed citations
13.
Sagawa, M., Hiroto Ohguchi, Takeshi Harada, et al.. (2017). Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma. Clinical Cancer Research. 23(17). 5225–5237. 30 indexed citations
14.
Ho, Matthew, Jiye Liu, Alireza Kalbasi, et al.. (2017). Blocking HDAC3 in Bone Marrow Stromal Cells Has Direct Anti-Multiple Myeloma Effect and Modulates T Cell Function. Blood. 130. 4429–4429. 2 indexed citations
15.
Harada, Takeshi, Shuji Ozaki, Asuka Oda, et al.. (2013). Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors. PLoS ONE. 8(12). e83905–e83905. 13 indexed citations
16.
Yamamura, Hideki, Yasuo Ohnishi, Jun Ishikawa, et al.. (2012). Complete genome sequence of the motile actinomycete Actinoplanes missouriensis 431T (= NBRC 102363T). Standards in Genomic Sciences. 7(2). 294–303. 29 indexed citations
17.
Harada, Takeshi, et al.. (2010). A case of endogenous fungal endophthalmitis developing after maxillofacial trauma. Japanese Journal of Oral & Maxillofacial Surgery. 56(12). 715–719. 1 indexed citations
18.
Ota, Yukihiro, et al.. (2009). A case of pleomorphic adenoma in the sublingual gland. Japanese Journal of Oral & Maxillofacial Surgery. 55(10). 510–513. 2 indexed citations
19.
Kadoya, Shinichi, et al.. (2003). A Case of Malignant Fibrous Histiocytoma of the Mesentery. The Japanese Journal of Gastroenterological Surgery. 36(11). 1593–1597. 1 indexed citations
20.
Yamauchi, Takeshi, et al.. (1996). Effect of Exercise-Induced Acidosis on the Performance of the Subsequent Exhaustive Exercise. 2(2). 79–82.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoko Yoshida Breakdown of academic impact, for papers by Xiaonan Wang Breakdown of academic impact, for papers by Liting Chen Breakdown of academic impact, for papers by Gerhard Weber Breakdown of academic impact, for papers by Kenji Saito Breakdown of academic impact, for papers by KM Taylor Breakdown of academic impact, for papers by Agnete Larsen Breakdown of academic impact, for papers by Yan Chen Breakdown of academic impact, for papers by Yanli Zhang Breakdown of academic impact, for papers by Xujun Wang
Rankless by CCL
2026